In general, Botox is the brand name for a botulin toxin type A, of which there are subtypes. The type B variety (BTX-B) is known as Neurobloc in the E.U. or Myobloc in the U.S.A. Both are employed in medical and/or therapeutic purposes. Botox itself is more popularly known for it’s non-surgical cosmetic function. It is also known as Vistabel in the E.U. and Dysport.
In the 1950s, although experimented with much earlier, very small injections of botulin toxin type A (BTX-A) were used to decrease overactive muscle activity. In that same period, it was experimented with in cosmetic treatments. In 1989, in the U.S., Allergan Inc. got approval from the F.D.A. and named their drug Botox. Approval for its cosmetic use came in 2002, when researchers discovered is cosmetic effects.
Technically speaking, botulin toxin type A (BTX-A) is produced by bacteria. Once processed, its injection serves to interfere with nerve impulses, amongst other things. As such, it has come to serve many purposes in non-surgical cosmetic treatment, namely the removal of lines. However, its effects are not permanent, so future injections may be required.
It has been used to treat...